[1]
“LOW-DOSE VERSUS STANDARD-DOSE RITUXIMAB IN VESICULOBULLOUS DISORDERS: A COMPARATIVE EFFECTIVENESS STUDY”, A-JMRHS, vol. 4, no. 2, pp. 1638–1642, Jul. 2026, Accessed: Jul. 14, 2026. [Online]. Available: https://www.ajmrhs.com/journal/article/view/666